Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Normal Tension Glaucoma

April 27, 2021

View Press Release Corporate presentation Contact us
Previous